ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy
ATP1A1 是黑色素瘤治疗的一个有希望的新靶点，可以通过其生理配体蟾蜍灵抑制以恢复靶向治疗效果
期刊:Cancer Cell International
影响因子:5.3
doi:10.1186/s12935-023-03196-y
Laura Soumoy, Aline Genbauffe, Lena Mouchart, Alexandra Sperone, Anne Trelcat, Léa Mukeba-Harchies, Mathilde Wells, Bertrand Blankert, Ahmad Najem, Ghanem Ghanem, Sven Saussez, Fabrice Journe
